Table 3. Correlation of mean expression levels (target gene/ GAPDH ^* 10⁻³) of 7 genes with clinico-pathologic parameters in the training set.

Gene Name	Gene expression levels
	Clinical conditions				Myometrial invasion				LVSI
	NEM	AEH	EEC	P*	<1/2	≧1/2	P+	no		Yes	P+
	N = 10	N = 10
uPA	2.82	9.04	15.01	<0.01	12.9	19.4	0.028	13.0		17.2	0.042
PLOD2	1.50	2.70	4.23	0.024	3.79	5.14	0.041	3.66		4.95	0.22
COL1A2	2.12	13.5	6.54	0.34	6.70	6.17	0.82	8.33		4.74	0.14
PSAT1	6.64	2.01	5.20	0.85	6.43	2.59	0.26	7.25		2.50	0.17
SLC2A1	0.19	2.47	3.18	0.52	3.14	3.25	0.92	2.30		4.35	0.06
GCLM	3.70	2.94	3.71	0.94	3.58	4.01	0.69	4.01		3.20	0.45
TTYH2	0.24	0.49	0.94	0.63	1.01	0.84	0.57	1.11		0.79	0.47
	Tumor grading				LN statuus			FIGO stage
	G1	G2	G3	P*	negative	positive	P+	I/II		III/IV	P+
	N = 58	N = 15	N = 12		N = 72	N = 13		N = 70		N = 15
uPA	15.0	15.1	14.5	0.99	12.1	34.1	<0.01	12.7		25.7	0.017
PLOD2	3.46	5.28	6.25	0.039	4.15	4.75	0.68	4.26		4.12	0.92
COL1A2	7.52	4.67	4.02	0.43	6.35	7.80	0.67	6.56		6.43	0.97
PSAT1	4.74	4.04	8.60	0.66	5.54	2.97	0.58	5.69		3.04	0.52
SLC2A1	2.84	3.51	4.49	0.54	3.02	4.21	0.43	3.07		3.72	0.64
GCLM	3.22	6.20	3.06	0.06	3.72	3.67	0.97	3.73		3.67	0.96
TTYH2	1.15	0.49	0.64	0.35	0.95	0.93	0.97	0.98		0.84	0.78

^*by Kruskal-Wallis test.

⁺by Mann-Whitney U test.